Effectiveness of “Priorix” Against Measles and Mumps Diseases in Children Born After 2004 in the United Kingdom: A Retrospective Case-control Study Using the Clinical Practice Research Datalink GOLD Database

Evidence on vaccine effectiveness (VE) may encourage vaccination and help fight the reemergence of measles and mumps in Europe. However, limited data exist on real-life effectiveness of individual measles, mumps and rubella (MMR) vaccines. This study evaluated VE of GSK’s MMR vaccine (“Priorix”) aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Povey, Michael, Aris, Emmanuel, Cheuvart, Brigitte, Hall, Gillian, Cohet, Catherine, Willame, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Vaccine Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104017/
https://www.ncbi.nlm.nih.gov/pubmed/33956757
http://dx.doi.org/10.1097/INF.0000000000003111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104017/
https://www.ncbi.nlm.nih.gov/pubmed/33956757
http://dx.doi.org/10.1097/INF.0000000000003111

Ejemplares similares